IL1B and chronic kidney disease: CKD patients commonly exhibit a state of low-grade systemic inflammation, characterized by persistently elevated levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), which may further amplify the intensity and duration of post-stroke neuroinflammatory responses, aggravating brain tissue damage (Afsar et al., 2016).